XENE - Xenon Pharmaceuticals Inc.
43.05
-0.740 -1.719%
Share volume: 1,127,122
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$43.79
-0.74
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-12-2024 | 02-27-2025 | 05-12-2025 | 08-11-2025 | 11-03-2025 | 02-26-2026 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 7.500 M | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 7.500 M | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | -100.00% | nan% | nan% | ||||
| Operating expenses | 59.041 M | 69.104 M | 73.676 M | 77.477 M | 80.238 M | 94.229 M | 96.336 M | 109.767 M | |
| Selling general and admin | 14.791 M | 19.402 M | 16.706 M | 18.005 M | 19.038 M | 19.244 M | 19.282 M | 22.068 M | |
| Research and development | 44.250 M | 49.702 M | 56.970 M | 59.472 M | 61.200 M | 74.985 M | 77.054 M | 87.699 M | |
| Total expenses | 59.041 M | 69.104 M | 73.676 M | 77.477 M | 80.238 M | 94.229 M | 96.336 M | 109.767 M | |
| 17.04% | 6.62% | 5.16% | 3.56% | 17.44% | 2.24% | 13.94% | |||
| Operating income | -59.041 M | -69.104 M | -73.676 M | -77.477 M | -72.738 M | -94.229 M | -96.336 M | -109.767 M | |
| Ebit | -58.874 M | -69.094 M | -73.439 M | -78.955 M | -72.703 M | -92.531 M | -96.425 M | -110.063 M | |
| Pretax income | -47.519 M | -58.257 M | -63.110 M | -69.533 M | -64.620 M | -85.332 M | -90.219 M | -104.723 M | |
| 22.60% | 8.33% | 10.18% | -7.07% | 32.05% | 5.73% | 16.08% | |||
| Income tax | 412.000 K | -333.000 K | -320.000 K | -3.848 M | 427.000 K | -626.000 K | 677.000 K | 538.000 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -47.931 M | -57.924 M | -62.790 M | -65.685 M | -65.047 M | -84.706 M | -90.896 M | -105.261 M | |
| -20.85% | -8.40% | -4.61% | 0.97% | -30.22% | -7.31% | -15.80% |